Skip to Main Content

Paper Details

Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
Sci Rep
64
2015
-, APCs, CD4, CD4(+), CD4(+) T cells, CD8(+, CD8(+) T cells, IFN, MHC class II, NY-ESO-1, NY-ESO-1-specific CD8(+) T cells, T cell receptor, TCR, TR, TR-, TR-CD4, Tumor antigen, antigen-presenting cells, antigen-specific CD4(+) T cells, cancer, cancer cells, human, human CD4(+) T-cell subset, human CD4(+) helper T-cell subset, immune cells, malignancy, patients, tumor, tumor-recognizing CD4(+) T cells
Author NameAffiliation
Lloyd J OldLudwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center
Sacha GnjaticLudwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticLudwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 5

Datasets

Release 1.2